[go: up one dir, main page]

UA95958C2 - Antibody that binds to cd22, immunoconjugates and uses therefor - Google Patents

Antibody that binds to cd22, immunoconjugates and uses therefor

Info

Publication number
UA95958C2
UA95958C2 UAA200815084A UAA200815084A UA95958C2 UA 95958 C2 UA95958 C2 UA 95958C2 UA A200815084 A UAA200815084 A UA A200815084A UA A200815084 A UAA200815084 A UA A200815084A UA 95958 C2 UA95958 C2 UA 95958C2
Authority
UA
Ukraine
Prior art keywords
antibody
binds
immunoconjugates
uses therefor
immunoconjugate
Prior art date
Application number
UAA200815084A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
мл. Эбенс Аллен Дж.
Алан М. Грей
Вей-Чин Лян
Янь В
Шан-Фань ЮЙ
Original Assignee
Дженентек, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дженентек, Инк. filed Critical Дженентек, Инк.
Publication of UA95958C2 publication Critical patent/UA95958C2/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention relates to an antibody that specifically binds to CD22, a polynucleotide encoding the antibody, a vector, a host cell, a process for the preparation of the antibody, a method of detecting the presence of CD22 in a biological sample, an immunoconjugate etc.
UAA200815084A 2006-05-30 2007-05-29 Antibody that binds to cd22, immunoconjugates and uses therefor UA95958C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80932806P 2006-05-30 2006-05-30

Publications (1)

Publication Number Publication Date
UA95958C2 true UA95958C2 (en) 2011-09-26

Family

ID=40892057

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200815084A UA95958C2 (en) 2006-05-30 2007-05-29 Antibody that binds to cd22, immunoconjugates and uses therefor

Country Status (4)

Country Link
CN (1) CN101490087B (en)
SI (1) SI2032606T1 (en)
UA (1) UA95958C2 (en)
ZA (1) ZA200809776B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110070227A1 (en) * 2009-09-18 2011-03-24 Anna-Marie Novotney-Barry Treatment of Autoimmune and Inflammatory Diseases
CN104428006B (en) * 2012-07-04 2017-09-08 弗·哈夫曼-拉罗切有限公司 The antigen-antibody conjugate of covalent attachment
CA2874856A1 (en) * 2012-07-09 2014-01-16 Genentech, Inc. Immunoconjugates comprising anti-cd79b antibodies
CA2873889A1 (en) * 2012-07-09 2014-01-16 Genentech, Inc. Anti-cd22 antibodies and immunoconjugates
SG11201500142RA (en) * 2012-07-09 2015-02-27 Genentech Inc Immunoconjugates comprising anti-cd22 antibodies
BR122021014396B1 (en) * 2012-10-11 2022-07-05 Daiichi Sankyo Company, Limited INTERMEDIATE DRUG BINDING COMPOUNDS, AND BINDING
US9872924B2 (en) 2012-10-19 2018-01-23 Daiichi Sankyo Company, Limited Antibody-drug conjugate produced by binding through linker having hydrophilic structure
JP6553515B2 (en) * 2012-12-20 2019-07-31 メディミューン，エルエルシー Method for producing immune complex
CN110420333A (en) * 2013-03-14 2019-11-08 斯克利普斯研究所 Targeting agent antibody coupling matter and application thereof
FR3008408B1 (en) * 2013-07-11 2018-03-09 Mc Saf NOVEL ANTIBODY-MEDICAMENT CONJUGATES AND THEIR USE IN THERAPY
KR102535900B1 (en) 2013-12-25 2023-05-26 다이이찌 산쿄 가부시키가이샤 Anti-trop2 antibody-drug conjugate
BR112016013482B1 (en) 2014-01-31 2022-04-19 Daiichi Sankyo Company, Limited ANTI-HER2-DRUG ANTIBODY CONJUGATE, ANTI-TUMOR AND/OR ANTI-CANCER DRUGS AND PHARMACEUTICAL COMPOSITION
ES2754348T3 (en) 2014-04-10 2020-04-17 Daiichi Sankyo Co Ltd Conjugate of (anti-HER2 antibody) -pharmaceutical
KR102445502B1 (en) 2014-04-10 2022-09-21 다이이찌 산쿄 가부시키가이샤 Anti-her3 antibody-drug conjugate
RU2017101681A (en) * 2014-06-20 2018-07-20 Биоэллаенс К.В. CONJUGATES ANTI-CD22 ANTIBODY - MEDICINAL PRODUCT AND WAYS OF THEIR APPLICATION
EP3233905B1 (en) * 2014-12-17 2020-01-29 F.Hoffmann-La Roche Ag Novel methods for enzyme mediated polypeptide conjugation using sortase
BR112017010888A2 (en) * 2014-12-17 2018-02-27 Hoffmann La Roche method for producing an enzyme conjugation product of three polypeptides
IL290959B2 (en) 2015-06-29 2023-04-01 Daiichi Sankyo Co Ltd Antibody-drug conjugate compisitions and methods for producing same
CN106467575B (en) * 2015-08-18 2020-07-31 四川百利药业有限责任公司 Cysteine engineered antibody-toxin conjugates
CN107029242A (en) 2015-11-03 2017-08-11 财团法人工业技术研究院 Antibody drug complex and method for producing same
US12102689B2 (en) * 2015-11-09 2024-10-01 R.P. Scherer Technologies, Llc Anti-CD22 antibody-maytansine conjugates and methods of use thereof
BR112019012847A2 (en) 2017-01-17 2019-12-10 Daiichi Sankyo Co Ltd antibody or antibody functional fragment, polynucleotide, expression vector, host cells, method for producing an antibody of interest or antibody functional fragment and for producing an antibody-drug conjugate, antibody-drug conjugate, pharmaceutical composition , antitumor drug; and, method of treating a tumor.
CN116672463A (en) * 2017-02-17 2023-09-01 浙江特瑞思药业股份有限公司 Preparation method of targeted CD20 antibody coupling drug, antibody coupling drug and application thereof
TWI794230B (en) 2017-05-15 2023-03-01 日商第一三共股份有限公司 Anti cdh6 antibodies and anti cdh6 antibody drug conjugates, as well as manufacturing method thereof
SG11202000997YA (en) 2017-08-31 2020-03-30 Daiichi Sankyo Co Ltd Improved method for producing antibody-drug conjugate
US11318212B2 (en) 2017-08-31 2022-05-03 Daiichi Sankyo Company, Limited Method for producing antibody-drug conjugate
JP2021501198A (en) * 2017-10-27 2021-01-14 トランスフュージョン ヘルス，リミティド ライアビリティ カンパニー Compositions and Methods for Proliferating Hematopoietic Stem Cells Using Fluorene Derivatives
NZ764948A (en) * 2017-11-30 2024-08-30 Ladrx Corp Albumin-binding prodrugs of auristatin e derivatives
CN108727499B (en) * 2018-04-24 2021-12-31 四川百利药业有限责任公司 Cysteine engineered antibody-toxin conjugates
CN112351999A (en) 2018-05-18 2021-02-09 第一三共株式会社 anti-MUC 1 antibody-drug conjugates
TWI822822B (en) 2018-07-31 2023-11-21 日商第一三共股份有限公司 Use of antibody-drug conjugate
CN109824759A (en) * 2019-03-08 2019-05-31 联宁（苏州）生物制药有限公司 A kind of Preparation Method And Their Intermediate of the drug-linker MC-MMAF for antibody drug conjugates
BR112022024930A2 (en) * 2020-06-08 2022-12-27 Baili Bio Chengdu Pharmaceutical Co Ltd CAMPTOTHECIN DRUG HAVING HIGH STABILITY HYDROPHILIC CONNECTION UNIT AND CONJUGATE THEREOF
CN112924665B (en) * 2021-02-19 2023-10-03 山东莱博生物科技有限公司 Antibody horseradish peroxidase marker and preparation and application thereof

Also Published As

Publication number Publication date
SI2032606T1 (en) 2014-02-28
CN101490087B (en) 2013-11-06
CN101490087A (en) 2009-07-22
ZA200809776B (en) 2010-03-31

Similar Documents

Publication Publication Date Title
UA95958C2 (en) Antibody that binds to cd22, immunoconjugates and uses therefor
UA94628C2 (en) Humanized monoclonal antibody that binds to steap-1 and use thereof
WO2009126934A3 (en) Detection and tratment of pancreatic, ovarian and other cancers
PL2326349T3 (en) Novel reagents and method for conjugating biological molecules
WO2010065568A3 (en) METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95
PH12014502054A1 (en) Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
AU2013207599A1 (en) Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof
MX2009003938A (en) Antibodies and immunoconjugates and uses therefor.
UA116618C2 (en) CONSTITUTION-BASED CYSTEINE ANTIBODY AGAINST CD79b
TN2011000232A1 (en) Antitumor combinations containing antibodies recognizing specifically cd38 melphalan
EP2515121A4 (en) Sample processing device, sample processing method, and reaction container used in these device and method
TW200741203A (en) Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody
WO2011053565A3 (en) Compositions and methods for detecting a tauopathy
WO2007067984A3 (en) Neutralizing antibodies against primate psgl-1 and uses therefor
WO2009051741A3 (en) Methods for processing generic chemical structure representations
UA99292C2 (en) Antibody which specifically binds to neuropilin-2b (nrp2b)
WO2007120787A3 (en) Methods of treating, diagnosing or detecting cancers associated with liv-1 overexpression
MY146366A (en) Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase
MX2009010751A (en) Compositions and methods of detection.
WO2008070333A3 (en) Automated detection of cancer and high grade hyperplasias
IL215322A0 (en) Method for detecting antibody against sith-1 in biological sample
WO2009120183A3 (en) System for the detection of a biological pathogen and use thereof
ZA200800253B (en) Method for the quantitative determination of poloxamers
EP2599865A4 (en) Anti-fdp monoclonal antibody, fdp measurement reagent and reagent kit using same, and fdp measurement method
GB201119585D0 (en) Assay